Author's posts
Alzheimer’s drug that slows cognitive decline gets FDA approval
The drug, lecanemab, removes a sticky protein from the brain called amyloid beta, which is thought to play a key role in the memory-robbing illness.
‘Morning after’ pill label changed to clarify it does not cause abortion
The drug works mainly by delaying ovulation, or possibly by preventing fertilization. regulators said.
Major effort needed to remove illegal vaping products, review finds
The report, by the Reagan-Udall Foundation for the FDA, said the agency’s Center for Tobacco Products has fallen short in laying out priorities and has been besieged by lawsuits.
New drugs to battle obesity: What you need to know
Getting the drugs has been a challenge for some patients as huge demand and production problems have led to supply shortages.
Weight-loss drugs are a milestone for the obese but expose health inequity
The new medications, developed for diabetes but highly effective for obesity, are far superior to older weight-loss drugs.
For new NCI director, work turns personal: She is diagnosed with cancer
Monica Bertagnolli learned just before Thanksgiving she had early-stage breast cancer, which is considered treatable and has a high survival rate.
FDA approves updated coronavirus shots for young children
The youngest Americans will have access to variant-targeting boosters already available to older children and adults.
Blood tests for Alzheimer’s are here. Here’s what you need to know.
The tests are designed to aid doctors in diagnosing a memory-destroying illness that affects 6.5 million people in the United States.
Is it Alzheimer’s? Families want to know, and blood tests may offer answers.
For the first time, simple blood tests are emerging as potentially crucial tools to help physicians pinpoint Alzheimer’s.
Experimental Alzheimer’s drug from Roche fails in trials
It is a discouraging development that underscores the challenges of developing treatments for the memory-robbing disease.
